Norman D. Schwartz
CIK 940805 · Auf SEC EDGAR ansehen ↗
Aktionärsaktivist
Erste SEC-Einreichung: 30. Oktober 2025 · Neueste: 30. Oktober 2025
Auf dieser Seite
- Insider bei Unternehmen, bei denen diese Person ein meldepflichtiger Insider ist.
- Insider-Transaktionen Jede Aktie, die diese Person gekauft oder verkauft hat, aus Formular 4-Einreichungen.
- Derivate Options- und andere Derivatebestände, die von dieser Person gemeldet werden.
- Vergütung Vorstandsvergütung, die in den Unternehmensvollmachten offengelegt wird.
Insider bei
Insider-Transaktionen
0 Käufe (P)
0 Verkäufe (S)
Netto:
$0
+ 100 nicht börsennotierte Transaktionen unten
letzte 12 Monate, basierend auf den unten gezeigten Transaktionen
Preisänderung im Vergleich zum aktuellen Kurs, bereinigt um Aktiensplits und Unternehmensmaßnahmen seit der Einreichung – nicht benchmarkt, nicht annualisiert, nicht größen-gewichtet
Keine Offenmarktgeschäfte verzeichnet; alle Einreichungen werden angezeigt.
| Date | Ticker | Code | Aktien | Kurs | Wert | Besessen danach | Δ Eigenbesitz | A/D | vs jetzt |
|---|---|---|---|---|---|---|---|---|---|
| 6. September 2025 | BIO | M | 3.455 | — | — | 10.367 Direkt | -25,00% | Veräußert | (Preis per 2026-08-20) |
| 6. September 2025 | BIO | F | 1.528 | $295,43 | $451.417 | 443.434 Direkt | -0,34% | Veräußert | 23,4% (Preis per 2026-08-20) |
| 6. September 2025 | BIO | M | 3.455 | — | — | 444.962 Direkt | +0,78% | Erworben | (Preis per 2026-08-20) |
| 5. September 2025 | BIO | A | 16.439 | — | — | 16.439 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 1. September 2025 | BIO | M | 3.005 | — | — | 6.010 Direkt | -33,33% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2025 | BIO | M | 2.082 | — | — | 2.082 Direkt | -50,00% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2025 | BIO | M | 1.266 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2025 | BIO | F | 3.084 | $297,88 | $918.662 | 441.507 Direkt | -0,69% | Veräußert | 22,4% (Preis per 2026-08-20) |
| 1. September 2025 | BIO | M | 6.353 | — | — | 444.591 Direkt | +1,45% | Erworben | (Preis per 2026-08-20) |
| 3. März 2025 | BIO | A | 11.671 | — | — | 11.671 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 6. September 2024 | BIO | A | 13.822 | — | — | 13.822 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 3. September 2024 | BIO | M | 2.320 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 3. September 2024 | BIO | F | 1.241 | $334,31 | $414.879 | 438.238 Direkt | -0,28% | Veräußert | 9,1% (Preis per 2026-08-20) |
| 3. September 2024 | BIO | M | 2.320 | — | — | 439.479 Direkt | +0,53% | Erworben | (Preis per 2026-08-20) |
| 2. September 2024 | BIO | M | 1.805 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 2. September 2024 | BIO | F | 965 | $337,32 | $325.514 | 437.159 Direkt | -0,22% | Veräußert | 8,1% (Preis per 2026-08-20) |
| 2. September 2024 | BIO | M | 1.805 | — | — | 438.124 Direkt | +0,41% | Erworben | (Preis per 2026-08-20) |
| 1. September 2024 | BIO | M | 1.266 | — | — | 1.266 Direkt | -50,00% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2024 | BIO | M | 2.081 | — | — | 4.164 Direkt | -33,32% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2024 | BIO | M | 3.005 | — | — | 9.015 Direkt | -25,00% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2024 | BIO | F | 545 | $337,32 | $183.839 | 436.319 Direkt | -0,12% | Veräußert | 8,1% (Preis per 2026-08-20) |
| 1. September 2024 | BIO | M | 1.266 | — | — | 436.864 Direkt | +0,29% | Erworben | (Preis per 2026-08-20) |
| 1. September 2024 | BIO | F | 801 | $337,32 | $270.193 | 435.598 Direkt | -0,18% | Veräußert | 8,1% (Preis per 2026-08-20) |
| 1. September 2024 | BIO | M | 2.081 | — | — | 436.399 Direkt | +0,48% | Erworben | (Preis per 2026-08-20) |
| 1. September 2024 | BIO | F | 1.607 | $337,32 | $542.073 | 434.318 Direkt | -0,37% | Veräußert | 8,1% (Preis per 2026-08-20) |
| 1. September 2024 | BIO | M | 3.005 | — | — | 435.925 Direkt | +0,69% | Erworben | (Preis per 2026-08-20) |
| 26. August 2024 | BIO | G | 57 | — | — | 13.006 Indirekt | +0,44% | Erworben | (Preis per 2026-08-20) |
| 26. August 2024 | BIO | G | 57 | — | — | 361.466 Direkt | +0,02% | Erworben | (Preis per 2026-08-20) |
| 8. März 2024 | BIO | A | 14.137 | — | — | 14.137 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 5. Dezember 2023 | BIO | G | 49 | — | — | 12.949 Indirekt | +0,38% | Erworben | (Preis per 2026-08-20) |
| 5. Dezember 2023 | BIO | G | 49 | — | — | 361.409 Direkt | +0,01% | Erworben | (Preis per 2026-08-20) |
| 1. November 2023 | BIO | M | 15.000 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 1. November 2023 | BIO | M | 16.000 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 1. November 2023 | BIO | M | 35.000 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 1. November 2023 | BIO | F | 12.024 | $273,00 | $3.282.552 | 361.360 Direkt | -3,22% | Veräußert | 33,6% (Preis per 2026-08-20) |
| 1. November 2023 | BIO | M | 15.000 | $159,32 | $2.389.800 | 373.384 Direkt | +4,19% | Erworben | 128,9% (Preis per 2026-08-20) |
| 1. November 2023 | BIO | F | 12.274 | $273,00 | $3.350.802 | 358.384 Direkt | -3,31% | Veräußert | 33,6% (Preis per 2026-08-20) |
| 1. November 2023 | BIO | M | 16.000 | $139,56 | $2.232.960 | 370.658 Direkt | +4,51% | Erworben | 161,3% (Preis per 2026-08-20) |
| 1. November 2023 | BIO | F | 25.642 | $273,00 | $7.000.266 | 354.658 Direkt | -6,74% | Veräußert | 33,6% (Preis per 2026-08-20) |
| 1. November 2023 | BIO | M | 35.000 | $119,80 | $4.193.000 | 380.300 Direkt | +10,14% | Erworben | 204,4% (Preis per 2026-08-20) |
| 1. September 2023 | BIO | A | 12.020 | — | — | 12.020 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 39.000 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 2.600 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 2.320 | — | — | 2.320 Direkt | -50,00% | Veräußert | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 1.805 | — | — | 1.805 Direkt | -50,00% | Veräußert | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 1.266 | — | — | 2.532 Direkt | -33,33% | Veräußert | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 2.081 | — | — | 6.245 Direkt | -24,99% | Veräußert | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | F | 25.389 | $381,78 | $9.693.012 | 345.300 Direkt | -6,85% | Veräußert | -4,5% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 39.000 | $117,50 | $4.582.500 | 370.689 Direkt | +11,76% | Erworben | 210,3% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | F | 1.290 | $381,78 | $492.496 | 432.920 Direkt | -0,30% | Veräußert | -4,5% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 2.600 | — | — | 434.210 Direkt | +0,60% | Erworben | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | F | 1.151 | $381,78 | $439.429 | 431.610 Direkt | -0,27% | Veräußert | -4,5% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 2.320 | — | — | 432.761 Direkt | +0,54% | Erworben | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | F | 895 | $381,78 | $341.693 | 430.441 Direkt | -0,21% | Veräußert | -4,5% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 1.805 | — | — | 431.336 Direkt | +0,42% | Erworben | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | F | 628 | $381,78 | $239.758 | 429.531 Direkt | -0,15% | Veräußert | -4,5% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 1.266 | — | — | 430.159 Direkt | +0,30% | Erworben | (Preis per 2026-08-20) |
| 25. August 2023 | BIO | F | 1.032 | $381,78 | $393.997 | 428.893 Direkt | -0,24% | Veräußert | -4,5% (Preis per 2026-08-20) |
| 25. August 2023 | BIO | M | 2.081 | — | — | 429.925 Direkt | +0,49% | Erworben | (Preis per 2026-08-20) |
| 7. November 2022 | BIO | G | 42 | — | — | 12.900 Indirekt | +0,33% | Erworben | (Preis per 2026-08-20) |
| 7. November 2022 | BIO | G | 42 | — | — | 331.689 Direkt | +0,01% | Erworben | (Preis per 2026-08-20) |
| 5. September 2022 | BIO | M | 2.600 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 5. September 2022 | BIO | F | 1.575 | $478,32 | $753.354 | 427.844 Direkt | -0,37% | Veräußert | -23,8% (Preis per 2026-08-20) |
| 5. September 2022 | BIO | M | 2.600 | — | — | 429.419 Direkt | +0,61% | Erworben | (Preis per 2026-08-20) |
| 4. September 2022 | BIO | M | 2.600 | — | — | 2.600 Direkt | -50,00% | Veräußert | (Preis per 2026-08-20) |
| 4. September 2022 | BIO | F | 1.575 | $478,32 | $753.354 | 426.819 Direkt | -0,37% | Veräußert | -23,8% (Preis per 2026-08-20) |
| 4. September 2022 | BIO | M | 2.600 | — | — | 428.394 Direkt | +0,61% | Erworben | (Preis per 2026-08-20) |
| 3. September 2022 | BIO | M | 2.319 | — | — | 4.640 Direkt | -33,32% | Veräußert | (Preis per 2026-08-20) |
| 3. September 2022 | BIO | F | 1.405 | $478,32 | $672.040 | 425.794 Direkt | -0,33% | Veräußert | -23,8% (Preis per 2026-08-20) |
| 3. September 2022 | BIO | M | 2.319 | — | — | 427.199 Direkt | +0,55% | Erworben | (Preis per 2026-08-20) |
| 2. September 2022 | BIO | M | 1.805 | — | — | 3.610 Direkt | -33,33% | Veräußert | (Preis per 2026-08-20) |
| 2. September 2022 | BIO | F | 1.094 | $478,32 | $523.282 | 424.880 Direkt | -0,26% | Veräußert | -23,8% (Preis per 2026-08-20) |
| 2. September 2022 | BIO | M | 1.805 | — | — | 425.974 Direkt | +0,43% | Erworben | (Preis per 2026-08-20) |
| 1. September 2022 | BIO | M | 1.266 | — | — | 3.798 Direkt | -25,00% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2022 | BIO | A | 8.326 | — | — | 8.326 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 1. September 2022 | BIO | F | 767 | $486,25 | $372.954 | 424.169 Direkt | -0,18% | Veräußert | -25,0% (Preis per 2026-08-20) |
| 1. September 2022 | BIO | M | 1.266 | — | — | 424.936 Direkt | +0,30% | Erworben | (Preis per 2026-08-20) |
| 26. August 2022 | BIO | M | 39.250 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 26. August 2022 | BIO | F | 23.749 | $495,28 | $11.762.405 | 331.647 Direkt | -6,68% | Veräußert | -26,4% (Preis per 2026-08-20) |
| 26. August 2022 | BIO | M | 39.250 | $107,32 | $4.212.310 | 355.396 Direkt | +12,42% | Erworben | 239,8% (Preis per 2026-08-20) |
| 9. November 2021 | BIO | G | 20 | — | — | 12.858 Indirekt | +0,16% | Erworben | (Preis per 2026-08-20) |
| 9. November 2021 | BIO | G | 20 | — | — | 316.146 Direkt | +0,01% | Erworben | (Preis per 2026-08-20) |
| 7. September 2021 | BIO | M | 37.000 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 7. September 2021 | BIO | M | 3.000 | — | — | 0 Direkt | -100,00% | Veräußert | (Preis per 2026-08-20) |
| 7. September 2021 | BIO | F | 20.660 | $806,32 | $16.658.571 | 316.126 Direkt | -6,13% | Veräußert | -54,8% (Preis per 2026-08-20) |
| 7. September 2021 | BIO | M | 37.000 | $100,06 | $3.702.220 | 336.786 Direkt | +12,34% | Erworben | 264,4% (Preis per 2026-08-20) |
| 7. September 2021 | BIO | F | 1.488 | $806,32 | $1.199.804 | 299.786 Direkt | -0,49% | Veräußert | -54,8% (Preis per 2026-08-20) |
| 7. September 2021 | BIO | M | 3.000 | — | — | 301.274 Direkt | +1,01% | Erworben | (Preis per 2026-08-20) |
| 5. September 2021 | BIO | M | 2.600 | — | — | 2.600 Direkt | -50,00% | Veräußert | (Preis per 2026-08-20) |
| 5. September 2021 | BIO | F | 1.290 | $819,70 | $1.057.413 | 423.670 Direkt | -0,30% | Veräußert | -55,5% (Preis per 2026-08-20) |
| 5. September 2021 | BIO | M | 2.600 | — | — | 424.960 Direkt | +0,62% | Erworben | (Preis per 2026-08-20) |
| 4. September 2021 | BIO | M | 2.600 | — | — | 5.200 Direkt | -33,33% | Veräußert | (Preis per 2026-08-20) |
| 4. September 2021 | BIO | F | 1.290 | $819,70 | $1.057.413 | 422.360 Direkt | -0,30% | Veräußert | -55,5% (Preis per 2026-08-20) |
| 4. September 2021 | BIO | M | 2.600 | — | — | 423.650 Direkt | +0,62% | Erworben | (Preis per 2026-08-20) |
| 3. September 2021 | BIO | M | 2.319 | — | — | 6.959 Direkt | -24,99% | Veräußert | (Preis per 2026-08-20) |
| 3. September 2021 | BIO | F | 1.150 | $819,70 | $942.655 | 421.050 Direkt | -0,27% | Veräußert | -55,5% (Preis per 2026-08-20) |
| 3. September 2021 | BIO | M | 2.319 | — | — | 422.200 Direkt | +0,55% | Erworben | (Preis per 2026-08-20) |
| 2. September 2021 | BIO | M | 1.805 | — | — | 5.415 Direkt | -25,00% | Veräußert | (Preis per 2026-08-20) |
| 1. September 2021 | BIO | A | 5.064 | — | — | 5.064 Direkt | — | Erworben | (Preis per 2026-08-20) |
| 1. September 2021 | BIO | A | 5.064 | — | — | 5.064 Direkt | — | Erworben | (Preis per 2026-08-20) |
Zeige die neuesten 100 von 256 Transaktionen
K = Kauf auf offener Markt · V = Verkauf · A = Zuteilung/Auszeichnung · M = Optionsausübung · G = Geschenk · F = Steuereinbehalt
Insider-Transaktionen sind keine Empfehlung; Verkäufe werden oft aus Liquiditäts- oder steuerlichen Gründen getätigt.
Derivate-Bestände (Formular 4 Tabelle II)
Optionen, RSUs und wandelbare Wertpapiere, die in Formular 4 Tabelle II gemeldet werden.
| Date | Ticker | Wertpapier | Basiswert | Ausübungspreis | Verfall | Aktien | A/D |
|---|---|---|---|---|---|---|---|
| 6. September 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3.455) | — | — | 3.455 | Veräußert |
| 5. September 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (16.439) | — | — | 16.439 | Erworben |
| 1. September 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3.005) | — | — | 3.005 | Veräußert |
| 1. September 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.082) | — | — | 2.082 | Veräußert |
| 1. September 2025 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.266) | — | — | 1.266 | Veräußert |
| 3. März 2025 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (11.671) | $256,45 | 3. März 2035 | 11.671 | Erworben |
| 6. September 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (13.822) | — | — | 13.822 | Erworben |
| 3. September 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.320) | — | — | 2.320 | Veräußert |
| 2. September 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.805) | — | — | 1.805 | Veräußert |
| 1. September 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.266) | — | — | 1.266 | Veräußert |
| 1. September 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.081) | — | — | 2.081 | Veräußert |
| 1. September 2024 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3.005) | — | — | 3.005 | Veräußert |
| 8. März 2024 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (14.137) | $343,76 | 8. März 2034 | 14.137 | Erworben |
| 1. November 2023 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (15.000) | $159,32 | 7. September 2026 | 15.000 | Veräußert |
| 1. November 2023 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (16.000) | $139,56 | 11. September 2025 | 16.000 | Veräußert |
| 1. November 2023 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (35.000) | $119,80 | 10. September 2024 | 35.000 | Veräußert |
| 1. September 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (12.020) | — | — | 12.020 | Erworben |
| 25. August 2023 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (39.000) | $117,50 | 11. September 2023 | 39.000 | Veräußert |
| 25. August 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.600) | — | — | 2.600 | Veräußert |
| 25. August 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.320) | — | — | 2.320 | Veräußert |
| 25. August 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.805) | — | — | 1.805 | Veräußert |
| 25. August 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.266) | — | — | 1.266 | Veräußert |
| 25. August 2023 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.081) | — | — | 2.081 | Veräußert |
| 5. September 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.600) | — | — | 2.600 | Veräußert |
| 4. September 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.600) | — | — | 2.600 | Veräußert |
| 3. September 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.319) | — | — | 2.319 | Veräußert |
| 2. September 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.805) | — | — | 1.805 | Veräußert |
| 1. September 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.266) | — | — | 1.266 | Veräußert |
| 1. September 2022 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (8.326) | — | — | 8.326 | Erworben |
| 26. August 2022 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (39.250) | $107,32 | 12. September 2022 | 39.250 | Veräußert |
| 7. September 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.000) | $100,06 | 4. November 2021 | 37.000 | Veräußert |
| 7. September 2021 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (3.000) | — | — | 3.000 | Veräußert |
| 5. September 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.600) | — | — | 2.600 | Veräußert |
| 4. September 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.600) | — | — | 2.600 | Veräußert |
| 3. September 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.319) | — | — | 2.319 | Veräußert |
| 2. September 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (1.805) | — | — | 1.805 | Veräußert |
| 1. September 2021 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (5.064) | $814,95 | 1. September 2031 | 5.064 | Erworben |
| 1. September 2021 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (5.064) | — | — | 5.064 | Erworben |
| 3. September 2020 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (2.319) | — | — | 2.319 | Veräußert |
| 12. Juni 2020 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.000) | $84,57 | 8. September 2020 | 37.000 | Veräußert |
| 13. Mai 2019 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.000) | $75,38 | 10. Juni 2019 | 37.000 | Veräußert |
| 11. Mai 2018 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.500) | $88,48 | 11. Juni 2018 | 37.500 | Veräußert |
| 25. August 2015 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (76.913) | $63,00 | 3. April 2016 | 76.913 | Veräußert |
| 9. Februar 2015 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (75.628) | $56,40 | 9. Februar 2015 | 75.628 | Veräußert |
| 4. November 2014 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 12. September 2014 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.617) | — | — | 2.617 | Veräußert |
| 11. September 2014 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.600) | — | — | 2.600 | Veräußert |
| 10. September 2014 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (10.000) | — | — | 10.000 | Erworben |
| 10. September 2014 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (35.000) | $119,80 | 10. September 2024 | 35.000 | Erworben |
| 8. September 2014 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 10. Juni 2014 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 15. November 2013 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (62.421) | $53,50 | 4. Februar 2014 | 62.421 | Veräußert |
| 4. November 2013 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 12. September 2013 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.617) | — | — | 2.617 | Veräußert |
| 11. September 2013 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (13.000) | — | — | 13.000 | Erworben |
| 11. September 2013 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (39.000) | $117,50 | 11. September 2023 | 39.000 | Erworben |
| 8. September 2013 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 10. Juni 2013 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 14. Dezember 2012 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (61.487) | $36,00 | 5. Februar 2013 | 61.487 | Veräußert |
| 4. November 2012 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 12. September 2012 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (13.085) | — | — | 13.085 | Erworben |
| 12. September 2012 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (39.250) | $107,32 | 12. September 2022 | 39.250 | Erworben |
| 8. September 2012 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 10. Juni 2012 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 14. Dezember 2011 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (2.072) | $28,88 | 6. Februar 2012 | 2.072 | Veräußert |
| 4. November 2011 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (12.000) | — | — | 12.000 | Erworben |
| 4. November 2011 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.000) | $100,06 | 4. November 2021 | 37.000 | Erworben |
| 8. September 2011 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 10. Juni 2011 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 3. April 2011 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (1.587) | $69,30 | 3. April 2011 | 1.587 | Veräußert |
| 14. September 2010 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (5.490) | $11,94 | 19. September 2010 | 5.490 | Veräußert |
| 8. September 2010 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (12.000) | — | — | 12.000 | Erworben |
| 8. September 2010 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.000) | $84,57 | 8. September 2020 | 37.000 | Erworben |
| 10. Juni 2010 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (2.400) | — | — | 2.400 | Veräußert |
| 10. Juni 2009 | BIO | Restricted Stock Units | Bio-Rad B Common Stock (12.000) | — | — | 12.000 | Erworben |
| 10. Juni 2009 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.000) | $75,38 | 10. Juni 2019 | 37.000 | Erworben |
| 11. Juni 2008 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.500) | $88,48 | 11. Juni 2018 | 37.500 | Erworben |
| 5. Februar 2008 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (6.296) | $39,60 | 5. Februar 2008 | 6.296 | Veräußert |
| 1. August 2007 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (37.500) | $75,00 | 1. August 2017 | 37.500 | Erworben |
| 6. Februar 2007 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (7.482) | $31,77 | 6. Februar 2007 | 7.482 | Veräußert |
| 6. Februar 2007 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (446) | $28,88 | 6. Februar 2012 | 446 | Veräußert |
| 6. Februar 2007 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (7.928) | $31,77 | 6. Februar 2007 | 7.928 | Veräußert |
| 3. April 2006 | BIO | Incentive Stock Option (right to buy) | Bio-Rad Common B (1.587) | — | 3. April 2011 | 1.587 | Erworben |
| 3. April 2006 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (1.587) | $63,00 | 3. April 2011 | 1.587 | Erworben |
| 3. April 2006 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (76.913) | $63,00 | 3. April 2016 | 76.913 | Erworben |
| 19. September 2005 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (12.010) | $13,14 | 19. September 2005 | 12.010 | Veräußert |
| 9. Februar 2005 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (1.772) | $62,04 | 9. Februar 2010 | 1.772 | Erworben |
| 9. Februar 2005 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (75.628) | $56,40 | 9. Februar 2015 | 75.628 | Erworben |
| 9. Februar 2005 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (1.739) | $62,04 | 9. Februar 2015 | 1.739 | Erworben |
| 9. Februar 2005 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (75.661) | $56,40 | 9. Februar 2015 | 75.661 | Erworben |
| 1. Februar 2005 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (7.500) | $12,44 | 2. Februar 2005 | 7.500 | Veräußert |
| 4. Februar 2004 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (1.869) | $58,85 | 4. Februar 2009 | 1.869 | Erworben |
| 4. Februar 2004 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (62.421) | $53,50 | 4. Februar 2014 | 62.421 | Erworben |
| 4. Februar 2004 | BIO | Incentive Stock Option | Class B Common Stock (3.737) | $58,85 | 4. Februar 2014 | 3.737 | Erworben |
| 4. Februar 2004 | BIO | Non Qualified Stock Option | Class B Common Stock (60.553) | $53,50 | 4. Februar 2014 | 60.553 | Erworben |
| 30. Januar 2004 | BIO | Incentive Stock Option | Bio-Rad Laboratories Class B Common Stock (7.500) | $10,45 | 3. Februar 2004 | 7.500 | Veräußert |
| 5. Februar 2003 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (6.296) | $39,60 | 5. Februar 2008 | 6.296 | Erworben |
| 5. Februar 2003 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (61.487) | $36,00 | 5. Februar 2013 | 61.487 | Erworben |
| 6. Februar 2002 | BIO | Incentive Stock Option (right to buy) | Bio-Rad B Common Stock (7.482) | $31,77 | 6. Februar 2007 | 7.482 | Erworben |
| 6. Februar 2002 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad B Common Stock (2.518) | $28,88 | 6. Februar 2012 | 2.518 | Erworben |
Ausübungs-/Umwandlungspreis ist leer, wenn nicht zutreffend (z. B. RSUs).
Vergütung (DEF 14A)
Nach Namen aus Stimmrechtsvollmacht-Erklärungen (DEF 14A) abgeglichen — gegen die Einreichung prüfen.
BIO
CEO| Geschäftsjahr | Gehalt | Bonus | Aktienprämien | Optionsprämien | Anreizprogramm außerhalb von Eigenkapital | Pensionsänderung | Andere | Gesamt |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.089.877 | — | — | — | $562.088 | — | $28.327 | $7.995.841 |
| 2023 | $1.040.000 | — | — | — | — | — | $212.341 | $7.463.878 |
| 2019 | $950.000 | — | $3.865.744 | $1.277.192 | $1.143.383 | — | $24.734 | $7.261.053 |
Angaben aus der Zusammenfassung der Vergütungstabelle (Summary Compensation Table) im Stimmrechtsbericht des Unternehmens (DEF 14A). Vergütung ist keine Empfehlung.